Since Mxd1 is downregulated by SIRT1 in 4C11- and 4C11+ tumor cell lines (Figure 4E and 4F), we have postulated that MAX could become more available to MYC binding in these melanoma cells. This evidence concerns the gene MXD1 and neoplasm.